152 related articles for article (PubMed ID: 21553103)
1. Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma.
Acikalin MF; Etiz D; Gurbuz MK; Ozudogru E; Canaz F; Colak E
Med Oncol; 2012 Jun; 29(2):742-9. PubMed ID: 21553103
[TBL] [Abstract][Full Text] [Related]
2. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy.
Hwang CF; Cho CL; Huang CC; Wang JS; Shih YL; Su CY; Chang HW
Ann Oncol; 2002 Aug; 13(8):1246-51. PubMed ID: 12181248
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma.
Huang SF; Cheng SD; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL
World J Surg Oncol; 2012 Feb; 10():40. PubMed ID: 22336657
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 and cyclin D1 expression in non-small cell lung cancer.
Kosacka M; Piesiak P; Kowal A; Gołecki M; Jankowska R
J Exp Clin Cancer Res; 2011 Oct; 30(1):101. PubMed ID: 22024187
[TBL] [Abstract][Full Text] [Related]
5. G1/S-specific cyclin-D1 might be a prognostic biomarker for patients with laryngeal squamous cell carcinoma.
Zhang YY; Xu ZN; Wang JX; Wei DM; Pan XL
Asian Pac J Cancer Prev; 2012; 13(5):2133-7. PubMed ID: 22901182
[TBL] [Abstract][Full Text] [Related]
6. Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
Lai JP; Tong CL; Hong C; Xiao JY; Tao ZD; Zhang Z; Tong WM; Betz CS
Laryngoscope; 2002 Feb; 112(2):402-8. PubMed ID: 11889405
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of cyclin D1 can act as an independent prognostic marker for longer survival time in human nasopharyngeal carcinoma.
Liu Y; Liu Q; Wang Z; Chen M; Chen Y; Li X; Huang D; Fan S; Xiong W; Li G; Zhang W
J Clin Lab Anal; 2020 Aug; 34(8):e23298. PubMed ID: 32697404
[TBL] [Abstract][Full Text] [Related]
8. LOX expression in primary nasopharyngeal carcinoma: correlation with prognostic parameters and outcome.
Hua YJ; Wang HY; Tang LQ; Chen QY; Shao JY; Mai HQ
Oncotarget; 2016 Feb; 7(7):8200-7. PubMed ID: 26882568
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma.
Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A
J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1 overexpression in nasopharyngeal carcinoma: effect on survival.
Chang SL; Li CF; Lin C; Lin YS
Acta Otolaryngol; 2014 May; 134(5):536-42. PubMed ID: 24646142
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Cyclin D1 Over-expression in Colorectal Cancer: An Experience from Madinah, Saudi Arabia.
Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2471-2476. PubMed ID: 31450922
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Livin expression in nasopharyngeal carcinoma after radiotherapy.
Liu AH; He AB; Tong WX; Peng XL; Tian Q; Wang H; Li XG; Xu HL
Cancer Radiother; 2016 Jul; 20(5):384-90. PubMed ID: 27373721
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Sugimoto K; Tai Y; Tokuda M
Int J Cancer; 2001 Jul; 95(4):209-15. PubMed ID: 11400112
[TBL] [Abstract][Full Text] [Related]
14. Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung.
Mathieu A; Saal I; Vuckovic A; Ransy V; Vereerstraten P; Kaltner H; Gabius HJ; Kiss R; Decaestecker C; Salmon I; Remmelink M
Mod Pathol; 2005 Sep; 18(9):1264-71. PubMed ID: 15832191
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.
Cheng CW; Liu YF; Yu JC; Wang HW; Ding SL; Hsiung CN; Hsu HM; Shieh JC; Wu PE; Shen CY
Ann Surg Oncol; 2012 Dec; 19(13):4129-39. PubMed ID: 22864797
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid synthase-associated protein with death domain: a prognostic factor for survival in patients with nasopharyngeal carcinoma.
Li J; Wen Q; Xu L; Wang W; Luo J; Chu S; Xie G; Shi L; Huang D; Li J; Fan S
Hum Pathol; 2014 Dec; 45(12):2447-52. PubMed ID: 25305096
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer.
Saitoh G; Sugio K; Ishida T; Sugimachi K
Oncol Rep; 2001; 8(4):737-43. PubMed ID: 11410775
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
Luo W; Fang W; Li S; Yao K
Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
